• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMÉRIEUX SA VIDAS® CMV IGG ASSAY; VIDAS® CMV IGG ASSAU

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMÉRIEUX SA VIDAS® CMV IGG ASSAY; VIDAS® CMV IGG ASSAU Back to Search Results
Catalog Number 30204
Device Problem False Positive Result (1227)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
A customer in (b)(6) notified biomérieux of discrepant results associated with vidas® cmv igg (reference 30204) related to false positive results.The customer reported the dilution factors of 1:429 which accounts for the high results.There is no indication or report from the laboratory or physician that the discrepant result led to an adverse event related to a patient's state of health.No incorrect information was reported to the physician because the results were identified as incorrect immediately.The customer reported there was approximately half an hour delay reporting results.An internal biomérieux investigation will be initiated.
 
Manufacturer Narrative
An internal biomérieux investigation concluded the following: the analysis of the batch history records showed no anomaly.There was no capa, nor non conformity for a similar issue in relation to the customer's anomaly.There was no other complaint for the same issue on the batch vidas (b)(6) lot 1005287390/170920-0.On march 09th, the product quality laboratory tested three internal samples ((b)(6)) on the retained kit vidas (b)(6) batch 1005287390/170920-0 on vidas pc.(b)(6), (b)(6) sample, target 3.1, the result was < 4 (b)(6).(b)(6), the same (b)(6) sample tested pure but with the dilution (1/428) entered in the vidas software.The result was (b)(6) (993 ua/ml).(b)(6), an equivocal sample, target 4.18, the result found: 4 ua/ml equivocal.(b)(6), a (b)(6) sample, tested pure the result was 176 ua/ml.(b)(6): the same (b)(6) sample tested pure but with the dilution (1/429) entered in the vidas software, the result was (b)(6) (77626 ua/ml).(b)(6): the same sample was tested with a manual dilution, the result is positive ( 232 ua/ml) consistent with the sample tested pure.The product quality laboratory reproduced the customer's anomaly.The concentrations are expressed in au/ml.Samples with (b)(6) concentrations > 400 au/ml should be reassayed after dilution by 1/4 in saline solution.If the dilution factor has not been entered when the work list was created (see user's manual), multiply the result by the dilution factor to obtain the sample concentration.For serological monitoring, to obtain an accurate serum titer, dilute the samples with concentrations > 150 au/ml in order to obtain a result ranging between 50-150 au/ml.Since no international standard is available for the determination of (b)(6), the vidas (b)(6) reagent is calibrated against collection sera.There is no drift linked to the reagent vidas (b)(6) lot 1005287390/170920-0.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS® CMV IGG ASSAY
Type of Device
VIDAS® CMV IGG ASSAU
Manufacturer (Section D)
BIOMÉRIEUX SA
chemin de l orme
marcy l etoile, rhone 69280
FR 
Manufacturer (Section G)
BIOMÉRIEUX SA
chemin de l orme
marcy l etoile, rhone 69280
FR  
Manufacturer Contact
ellen weltmer
595 anglum road
saint louis, MO 63042
MDR Report Key6377068
MDR Text Key69110204
Report Number3002769706-2017-00042
Device Sequence Number1
Product Code LFZ
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K920661
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 04/07/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/03/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number30204
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/14/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-